Founded in 2010 by Dr. Luke Nordquist, XCancer® Omaha has become a globally recognized center of excellence in prostate cancer care and research. Renowned for its leadership in diagnostic and therapeutic innovation, Dr. Nordquist and his team have led over 20 First-in-World clinical advancements, including landmark contributions to Ga-68 PSMA PET imaging and Lu-177 PSMA therapy. Each month, more than 450 prostate cancer patients from over 40 U.S. states and multiple countries travel to XCancer® for its unparalleled expertise, rapid access to cutting-edge clinical trials, and compassionate, high-quality care.

TheranosticTrials.Org is the world’s leading platform for comprehensive access to everything related to cancer Theranostic Trials. It serves as a centralized hub that connects all stakeholders—researchers, clinicians, industry partners, patients, and advocates—across the global theranostics Ecosystem. The platform offers real-time statistics, comprehensive information and education on every theranostic clinical trial, educational resources, and tools that support collaboration and strategic development. With a mission to accelerate access to these novel diagnositc & therapeutic agents, TheranosticTrials.Org empowers innovation and fosters a connected, informed community at the forefront of cancer care. TheranosticTrials.Org was founded by XCancer.

XCancer Consulting, led by Dr. Luke Nordquist, is a globally recognized expert in prostate cancer & conducting clinical trials and has emerged as a pioneering force in radiopharmaceutical and theranostic trial development. With over 50 radiopharmaceutical trials led, including several of them First-in-World, Dr. Nordquist brings unmatched real-world insight into community oncology, patient accrual, and rapid trial activation. As CEO of XCancer® and founder of TheranosticTrials.org, his consulting services offer immense value to pharmaceutical sponsors, CROs, and biotech innovators aiming to design, scale, and execute high-impact prostate cancer and theranostic programs.

The XCancer Research Network is a pioneering clinical trials network that empowers community cancer centers across the United States to conduct cutting-edge, and even First-in-World oncology clinical trials. Built on the expertise and globally recognized reputation of XCancer and led by Dr. Luke Nordquist, the network provides a comprehensive research backbone encompassing trial identification, regulatory oversight, data management, contracts, finances, operations, and strategic guidance. This streamlined support enables centers to launch trials within weeks and offer patients access to the most advanced treatments available. Through strong partnerships with innovative sponsors and CROs, XCancer ensures a robust and diverse pipeline of trials across all cancer types—bringing more options and renewed hope to patients closer to home. Expanding the reach of Cancer Innovations.

The XCancer Foundation is a nonprofit organization dedicated to Expanding the Reach of Cancer Innovations by improving global access to cutting-edge cancer treatments, education, and clinical trials. Founded by Dr. Luke Nordquist, the Foundation works to break down barriers in cancer care, support community cancer centers, and reach underserved populations worldwide. From Omaha to East Africa, its mission is to ensure that life-saving innovations are not limited by geography or resources, bringing hope, healing, and high-impact care to patients everywhere.

The XCancer Store offers a unique way for supporters, caregivers, and advocates to express solidarity with cancer patients by providing thoughtfully designed merchandise that uplifts and empowers. Every purchase not only honors the cancer fighters in our lives but also contributes to a greater mission, supporting the XCancer Foundation. All proceeds go directly to the Foundation’s efforts to expand access to life-saving cancer innovations, especially through its impactful global work in underserved regions like Tanzania, Africa. By shopping at the XCancer Store, you're not just buying gear, you’re joining a movement to Expanding the Reach of Cancer Innovations around the world.

XCancer® Software has developed proprietary digital tools that continue to evolve, driving the transformation of cancer care through technology-enabled research solutions. As an innovative digital backbone, XCancer Software streamlines and advances cancer clinical trials, especially within community cancer centers. Anchored by platforms such as XCancerSuite—which enables rapid trial activation and high-quality data management—and TheranosticTrials.org—a global search engine for radiopharmaceutical clinical trials—this ecosystem supports a mission to reduce healthcare disparities, expand trial access, and enhance patient education in the growing field of Theranostics.

XCancer Health Physics Services offer comprehensive radiation safety and regulatory consulting tailored to facilities developing or expanding radiopharmaceutical programs. With over 30 years of specialized experience in nuclear medicine, XCancer’s team provides end-to-end support, including radiation protection program development, strategy, shielding evaluations, licensing assistance, equipment testing, and training. Their services ensure full regulatory compliance, operational safety, and streamlined clinical integration, empowering sites to confidently navigate the complexities of radiopharmaceutical implementation and accelerate their theranostic capabilities.

XCancer Motorsports is a one-of-a-kind racing team that fuses the adrenaline and ambition of professional motorsport with a powerful mission: raising awareness and support for cancer research, early detection, and education around clinical trials. Competing in the USF Pro Championship Series, a pivotal step on the Road to Indy, the team is led by rising talent Thomas Nordquist and backed by DEForce Racing.

XCancer Motorsports was founded by Dr. Luke Nordquist, a medical oncologist and CEO of XCancer®, who is internationally recognized for leading groundbreaking “first in world” cancer trials and for expanding access to the most advanced therapies through the XCancer Network. Dr. Nordquist's mission has revolutionized how and where patients receive cutting-edge cancer treatment, bringing life-saving innovations closer to home. This unmatched expertise and international reputation in cancer care bring credibility, authenticity, and a meaningful sense of purpose to the motorsport’s community.

Harnessing Thomas Nordquist’s rapidly growing social media presence and the expansive visibility of racing, XCancer Motorsports connects with fans to inspire, educate, and fundraise. Through compelling digital content, charitable events, and strategic partnerships with healthcare and philanthropic organizations, XCancer Motorsports is far more than a racing team—it’s a movement that unites hope, speed, and science in the fight against cancer, both on and off the track.